Insider: Saint Sean President & CEO - Beta Bionics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 437,809 | 0 | 437,809 |
| Value | $4,347,443.37 | $0.00 | $4,347,443.37 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | DDS | 3,384 | Direct | COM | $12.36 | $41,831.65 | 437,809 |
| 12/02/2025 | DDS | 3,278 | Direct | COM | $29.34 | $96,163.08 | 97,924 |
| 09/02/2025 | DDS | 3,359 | Direct | COM | $18.86 | $63,361.49 | 101,202 |
| 06/02/2025 | DDS | 943 | Direct | COM | $17.03 | $16,057.40 | 107,057 |
| 06/02/2025 | DDS | 2,185 | Direct | COM | $18.15 | $39,655.35 | 104,872 |
| 06/02/2025 | DDS | 311 | Direct | COM | $18.69 | $5,812.90 | 104,561 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research